FI82246B - Foerfarande foer framstaellning av ett farmakologiskt aktiva 6-purinyl-n-/2-kloretyl/karbamat eller tiokarbamat. - Google Patents

Foerfarande foer framstaellning av ett farmakologiskt aktiva 6-purinyl-n-/2-kloretyl/karbamat eller tiokarbamat. Download PDF

Info

Publication number
FI82246B
FI82246B FI855089A FI855089A FI82246B FI 82246 B FI82246 B FI 82246B FI 855089 A FI855089 A FI 855089A FI 855089 A FI855089 A FI 855089A FI 82246 B FI82246 B FI 82246B
Authority
FI
Finland
Prior art keywords
animals
substance
purinyl
tumor
thiocarbamate
Prior art date
Application number
FI855089A
Other languages
English (en)
Finnish (fi)
Other versions
FI855089A (fi
FI855089A0 (fi
FI82246C (sv
Inventor
Antonin Cerny
Jiri Krepelka
Milan Melka
Milan Miko
Stanislava Pokorna
Ruzena Reichlova
Irena Kejhova
Marta Beitova
Jaroslava Grimova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of FI855089A0 publication Critical patent/FI855089A0/fi
Publication of FI855089A publication Critical patent/FI855089A/fi
Application granted granted Critical
Publication of FI82246B publication Critical patent/FI82246B/fi
Publication of FI82246C publication Critical patent/FI82246C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (2)

1. Förfarande för framställning av ett farmakologiskt aktivt 6-purinyl-N-(2-kloretyl)karbamat eller -tiokarbamat med den allmänna formeln X-C0NHCH2CH2C1 (i) i*X> H väri X är en syre- eller svavelatom, kännetecknat av att ett 6-substituerat purinderivat med den allmänna formeln XH N IT Νϊ> (ID H väri X har den i formeln I angivna betydelsen, omsättes med ett 2-kloretylisocyanat med formeln C1-CH2-CH2-N=C=0 (III) i ett inert medium vid en temperatur som är väsentligen inom omrädet 0 - 50°C, företrädesvis i närvaro av ett al-kaliskt medel.
2. Förfarande enligt patentkravet 1, kännetecknat av att man som alkaliskt medel använder trietylamin.
FI855089A 1984-12-22 1985-12-19 Förfarande för framställning av ett farmakologiskt aktiva 6-purinyl-N- /2-kloretyl/karbamat eller tiokarbamat FI82246C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS8410291A CS249576B1 (en) 1984-12-22 1984-12-22 6-purinyl n-(2-chlorethyl)carbamate and thiocarbamate and method of their production
CS1029184 1984-12-22

Publications (4)

Publication Number Publication Date
FI855089A0 FI855089A0 (fi) 1985-12-19
FI855089A FI855089A (fi) 1986-06-23
FI82246B true FI82246B (fi) 1990-10-31
FI82246C FI82246C (sv) 1991-02-11

Family

ID=5448550

Family Applications (1)

Application Number Title Priority Date Filing Date
FI855089A FI82246C (sv) 1984-12-22 1985-12-19 Förfarande för framställning av ett farmakologiskt aktiva 6-purinyl-N- /2-kloretyl/karbamat eller tiokarbamat

Country Status (6)

Country Link
US (1) US4720497A (sv)
EP (1) EP0186454B1 (sv)
JP (1) JPS61186382A (sv)
CA (1) CA1260935A (sv)
CS (1) CS249576B1 (sv)
FI (1) FI82246C (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS249576B1 (en) * 1984-12-22 1987-04-16 Antonin Cerny 6-purinyl n-(2-chlorethyl)carbamate and thiocarbamate and method of their production
US6866797B1 (en) 2000-08-03 2005-03-15 Bj Services Company Corrosion inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH501652A (de) * 1966-07-01 1971-01-15 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von N-( -(6-Purinylthio)-valeryl)-aminosäureestern
GR75219B (sv) * 1980-04-21 1984-07-13 Merck & Co Inc
CS249576B1 (en) * 1984-12-22 1987-04-16 Antonin Cerny 6-purinyl n-(2-chlorethyl)carbamate and thiocarbamate and method of their production

Also Published As

Publication number Publication date
FI855089A (fi) 1986-06-23
FI855089A0 (fi) 1985-12-19
FI82246C (sv) 1991-02-11
JPH0586791B2 (sv) 1993-12-14
EP0186454A3 (en) 1989-03-08
CS1029184A1 (en) 1985-08-15
EP0186454A2 (en) 1986-07-02
CA1260935A (en) 1989-09-26
EP0186454B1 (en) 1992-04-08
CS249576B1 (en) 1987-04-16
JPS61186382A (ja) 1986-08-20
US4720497A (en) 1988-01-19

Similar Documents

Publication Publication Date Title
EP0031237B1 (en) Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US5597831A (en) 6-[X-(2-hydroxyethyl) aminoalkyl]-5,11-dioxo-5,6-dihydro-11-H-indeno[1,2-c]isoquinolines and their use as antineoplastic agents
US8188133B2 (en) Imidazole derivatives, preparation and user thereof as medicine
Rosowsky et al. Lipophilic 5'-alkyl phosphate esters of 1-. beta.-D-arabinofuranosylcytosine and its N4-acyl and 2, 2'-anhydro-3'-O-acyl derivatives as potential prodrugs
US9481678B2 (en) Substituted pyrrolo[2,3-D]dipyrimidines for selectively targeting tumor cells with FR-alpha and FR-beta type receptors
EP2656843B1 (en) Esters of bendamustine and related compounds, and medical use thereof
CN113143965B (zh) 一种抑制肿瘤增殖的氨基富勒烯材料
AU663729B2 (en) 6((2-hydroxyethyl)aminoalkyl)-5,11-dioxo-5,6-dihydro-11-H- indeno-(1,2-C)isoquinoline and their use as antineoplastic agents
FI82246B (fi) Foerfarande foer framstaellning av ett farmakologiskt aktiva 6-purinyl-n-/2-kloretyl/karbamat eller tiokarbamat.
US7700560B2 (en) Inactivators and bivalent inhibitors of glyoxalase I and methods of inhibiting tumor growth
Martinelli et al. Methotrexate analogs. 12. Synthesis and biological properties of some aza homologs
AU700658B2 (en) Selected soluble esters of hydroxyl-containing indolocarbazoles
Rosowsky et al. Synthesis and biological activity of the 2-desamino and 2-desamino-2-methyl analogs of aminopterin and methotrexate
Rosowsky et al. Discussion Paper: Synthesis and Biological Activity of Tricyclic Antifolate Compounds with Fixed Geometry
CS271331B2 (en) Method of mitomycin's n7-amidino-substituted derivatives production
JPH0441145B2 (sv)
EP0160910A2 (en) 7-Deazapurine derivatives and their production
RU2253446C1 (ru) Противоопухолевое средство
KR101263263B1 (ko) 항암활성을 가지는 2,4-다이아미노퀴나졸린 화합물
Yakhontov et al. Search for medicinal preparations in the series of 1, 3, 5-triazines
Kuznetsova et al. Effect of ephedrine and its derivatives in KML cell culture and on tumor strains of animals
AU2004313931A1 (en) 2-amino-O4-substituted pteridines and their use as inactivators of O6-alkylguanine-DNA alkyltransferase
MXPA97007632A (en) Soluble stereo selected from indolocarbazoles containing hidrox

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SPOFA SPOJENE PODNIKU PRO ZDRAVOTNICKOU